Germany Cell and Gene Therapy Manufacturing QC Market Size
According to Straits Research analysis, the Germany Cell and Gene Therapy Manufacturing QC Market was valued at USD 62.34 Million in 2024 and is projected to reach USD 151.28 Million by 2028, expanding at a CAGR of 24.9% during the forecast period. Primary demand is driven by industries such as agriculture, chemicals, and energy, where these therapies are utilized for crop enhancement, genetic modification, and renewable energy development, respectively. Technological advancements in the cell and gene sector are the key to market growth, coupled with Germany’s focus on environmentally-friendly, low-carbon production processes that bolster sustainability. As the nation broadens its export portfolio, potential job creation may fuel further expansion. With a forward-thinking approach, Germany is positioning itself as a hub for innovation and sustainability within the global cell and gene therapy market.
Source: Straits Research Analysis Company Publications, Primary Interviews.
Germany Cell and Gene Therapy Manufacturing QC Market Highlights
- Within the Therapy Type category, Cell Therapy dominated in 2024 in terms of market size contribution.
- Over the forecast period, Gene Therapy is forecasted to deliver the fastest growth, positioning it as the most lucrative Therapy Type segment.
- As of 2024, Germany held 2.79% of the global cell and gene therapy manufacturing qc market size.
- By 2028, United States is anticipated to capture the largest share of the global cell and gene therapy manufacturing qc market.
- In Europe, Germany is expected to lead the regional cell and gene therapy manufacturing qc market size by 2028.
- France will remain the fastest-growing market in Europe, reaching USD 45534 Million by 2028.
- 📊 Preview Report Scope and Structure – Gain immediate visibility into key topics, market segments, and data frameworks covered.
- 📥 Evaluate Strategic Insights – Access selected charts, statistics, and analyst-driven commentary derived from the final report deliverables.
Report Summary
| Report Scope |
Details |
| Base Year for Study |
2024 |
| Study Period |
2021-2028 |
| Historical Period |
2021-2023 |
| Forecast Period |
2025-2028 |
| Market Size In 2024 |
USD 62.34 Million |
| Market Size In 2028 |
USD 151.28 Million |
| Largest segment |
Cell Therapy |
| Fastest segment |
Gene Therapy |
| Units |
Revenue in USD Million |
| CAGR |
24.9% (2025-2028) |
| Report Coverage |
Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends |
Germany Cell and Gene Therapy Manufacturing QC Market Share By Therapy Type
Segmentation Covered
| Segments |
Sub Segments |
| Therapy Type |
- Cell Therapy
- Gene Therapy
|
| Cell Therapy |
- CAR-T
- CAR-NK
- B-Cell
- Other
|
| CAR-T |
- Autologous CAR-T
- Allogeneic CAR-T
|
| Gene Therapy |
- Viral
- Non-Viral
|
| Viral |
- AAV
- Lentiviral vectors
- Other
|
| Scale |
- Pre commercial/ R&D Manufacturing
- Commercial Scale Manufacturing
|
| Mode |
- Contract Manufacturing
- In-house Manufacturing
|
| Workflow |
- Cell Processing
- Cell Banking
- Fill & Finish Operations
- Raw Material Testing
- Vector Production
- Other Workflows
|
| Process |
- Upstream Processes
- Downstream Processes
|
| End User |
- Pharmaceutical Companies
- Biopharmaceutical / Biotechnological Companies
- Contract Manufacturing Organizations
|
| Pharmaceutical Companies |
- Small Size
- Medium Size
- Large Size
|
| Biopharmaceutical / Biotechnological Companies |
- Small Size
- Medium Size
- Large Size
|
| Contract Manufacturing Organizations |
- Small Size
- Medium Size
- Large Size
|
| Technology Type |
- Fluorescence-Activated Cell Sorting (FACS)
- Enzyme-Linked Immunosorbent Assay (ELISA)
- Chromatography
- Next-Generation Sequencing (NGS)
- Polymerase Chain Reaction (PCR)
- Others
|
Germany Cell and Gene Therapy Manufacturing QC Market By Therapy Type 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
Germany Cell and Gene Therapy Manufacturing QC Market By Cell Therapy 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
Germany Cell and Gene Therapy Manufacturing QC Market By CAR-T 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
Germany Cell and Gene Therapy Manufacturing QC Market By Gene Therapy 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
Germany Cell and Gene Therapy Manufacturing QC Market By Viral 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
Germany Cell and Gene Therapy Manufacturing QC Market By Scale 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
Germany Cell and Gene Therapy Manufacturing QC Market By Mode 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
Germany Cell and Gene Therapy Manufacturing QC Market By Workflow 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
Germany Cell and Gene Therapy Manufacturing QC Market By Process 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
Germany Cell and Gene Therapy Manufacturing QC Market By End User 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
Germany Cell and Gene Therapy Manufacturing QC Market By Pharmaceutical Companies 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
Germany Cell and Gene Therapy Manufacturing QC Market By Biopharmaceutical / Biotechnological Companies 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
Germany Cell and Gene Therapy Manufacturing QC Market By Contract Manufacturing Organizations 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
Germany Cell and Gene Therapy Manufacturing QC Market By Technology Type 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.